本页面由Tiger Trade Technology Pte. Ltd.提供服务

CVRx, Inc.

7.67
+0.02000.26%
成交量:24.37万
成交额:189.03万
市值:2.01亿
市盈率:-3.75
高:7.96
开:7.64
低:7.39
收:7.65
52周最高:14.02
52周最低:4.30
股本:2,621.01万
流通股本:1,796.41万
量比:0.65
换手率:1.36%
股息:- -
股息率:- -
每股收益(TTM):-2.0436
每股收益(LYR):-2.0436
净资产收益率:-96.59%
总资产收益率:-26.90%
市净率:5.11
市盈率(LYR):-3.75

数据加载中...

公司资料

公司名字:
CVRx, Inc.
交易所:
NASDAQ
成立时间:
2000
员工人数:
223
公司地址:
9201 West Broadway Avenue,Suite 650,Minneapolis,Minnesota,United States
邮编:
55445
电话:
传真:
763 416 2841
简介:
CVRx, Inc.于2000年8月在特拉华州注册成立,是一家商业阶段的医疗器械公司,致力于为心血管疾病患者开发、制造创新的神经调节解决方案并将其商业化。该公司的旗舰产品Barostim是美国食品药品监督管理局(FDA)批准的首个利用神经调节缓解心力衰竭(HF)症状的医疗技术。这种可植入设备有助于改善大脑自主神经系统(ANS)中的信号传导,以抵消HF的不利影响。

董事

名称
职位
Kevin Hykes
Director, President and Chief Executive Officer
Joseph Slattery
Independent Lead Director
Kevin J. Ballinger
Independent Director
Kirk Nielsen
Lead Independent Director
Martha Shadan
Independent Director
Mitchell C. Hill
Independent Director
Mudit K. Jain
Independent Director

股东

名称
职位
Kevin Hykes
Director, President and Chief Executive Officer
Brent Binkowski
Chief Operating Officer
Jared Oasheim
Chief Financial Officer and Principal Accounting Officer
Paul Verrastro
Chief Marketing Officer and Chief Strategy Officer
Philip B. Adan
Chief Medical Officer
Robert Allen John
Chief Revenue Officer